MNIVF (Monash IVF Group) Cyclically Adjusted Revenue per Share: $0.39 (As of Dec. 2025)


MNIVF Monash IVF Group Ltd MNIVF
78 GF Score
Price $0.40
GF Value $0.79
! 7 Warning Signs
View Full Analysis

What is Monash IVF Group Cyclically Adjusted Revenue per Share?

Monash IVF Group MNIVF 78 Cyclically Adjusted Revenue per Share is $0.39 as of Dec. 2025. GuruFocus rates MNIVF with a GF Score™ of 78/100 and a GF Value™ of $0.79. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Monash IVF Group's adjusted revenue per share data for the fiscal year that ended in Jun. 2025 was $0.454. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.39 for the trailing ten years ended in Jun. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-07), Monash IVF Group's current stock price is $ 0.40. Monash IVF Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun. 2025 was $0.39. Monash IVF Group's Cyclically Adjusted PS Ratio of today is 1.03.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Monash IVF Group was 2.20. The lowest was 0.90. And the median was 1.75.


Monash IVF Group  (OTCPK:MNIVF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Monash IVF Group's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.40/0.39
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Monash IVF Group was 2.20. The lowest was 0.90. And the median was 1.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Monash IVF Group Cyclically Adjusted Revenue per Share Related Terms


Monash IVF Group Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Monash IVF Group's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monash IVF Group Cyclically Adjusted Revenue per Share Chart

Monash IVF Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.39

Monash IVF Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.39 0.00

MNIVF vs TMO, DHR, IDXX: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Monash IVF Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monash IVF Group Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's Cyclically Adjusted PS Ratio falls into.


MNIVF
78GF Score
Monash IVF Group Ltd MNIVF
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Monash IVF Group Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Monash IVF Group's adjusted Revenue per Share data for the fiscal year that ended in Jun. 2025 was:

Adj_RevenuePerShare=Revenue per Share /CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=0.454/131.5506*131.5506
=0.454

Current CPI (Jun. 2025) = 131.5506.

Monash IVF Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.460 0.000
201706 0.463 0.000
201806 0.448 0.000
201906 0.418 0.000
202006 0.390 0.000
202106 0.357 0.000
202206 0.347 0.000
202306 0.368 0.000
202406 0.434 0.000
202506 0.454 131.551 0.454

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.39 mean?
Monash IVF Group (MNIVF) has a Cyclically Adjusted Revenue per Share of $0.39 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Monash IVF Group and its competitors.
Is Monash IVF Group's Cyclically Adjusted Revenue per Share too high?
Monash IVF Group's current Cyclically Adjusted Revenue per Share is $0.39. Overall, Monash IVF Group has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's Cyclically Adjusted Revenue per Share compare to TMO and DHR?
Monash IVF Group's Cyclically Adjusted Revenue per Share of $0.39 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current Cyclically Adjusted Revenue per Share is $0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current Cyclically Adjusted Revenue per Share of $0.39. The stock's GF Value™ is $0.79, compared to a current price of $0.40 — trading 49.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.39. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current Cyclically Adjusted Revenue per Share is $0.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 49.4% below its estimated GF Value™ of $0.79.

Key valuation signals for MNIVF:

  • Cyclically Adjusted Revenue per Share: $0.39
  • GF Value™: $0.79 vs. price of $0.40 (49.4% below fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Monash IVF Group Business Description

Other Exchanges MVF:Australia
Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score

Get the complete analysis for MNIVF

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.79
GF Value